Welcome to HealthTech Check Up! Hosts Rachelle Galant and Perry Dimas sit down to chat about one of healthcare’s most complex and long-debated topics: price transparency. From baby steps in shoppable services to the latest White House executive orders and the controversial rollout of a government-run drug pricing website, Rachel and Perry explore what’s driving this new wave of disruption in 2025. They unpack how these shifts could impact patients, payers, and PBMs, and what it means fo...
All content for HealthTech Check Up is the property of careviso and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Welcome to HealthTech Check Up! Hosts Rachelle Galant and Perry Dimas sit down to chat about one of healthcare’s most complex and long-debated topics: price transparency. From baby steps in shoppable services to the latest White House executive orders and the controversial rollout of a government-run drug pricing website, Rachel and Perry explore what’s driving this new wave of disruption in 2025. They unpack how these shifts could impact patients, payers, and PBMs, and what it means fo...
Rewriting Healthcare: How Stories, AI, and Strategy Are Shaping Healthcare
HealthTech Check Up
29 minutes
5 months ago
Rewriting Healthcare: How Stories, AI, and Strategy Are Shaping Healthcare
Welcome to HealthTech Check Up! On this week's episode, your hosts Rachelle Galant and Perry Dimas are chatting with Ryan Flinn, communications consultant, biotech strategist, and former Bloomberg journalist—to explore how storytelling, artificial intelligence, and innovative technologies are transforming the healthcare landscape. Ryan shares his unique journey from classics major to journalist to biotech communicator, revealing how clear, human-centered storytelling is key to navigating a wo...
HealthTech Check Up
Welcome to HealthTech Check Up! Hosts Rachelle Galant and Perry Dimas sit down to chat about one of healthcare’s most complex and long-debated topics: price transparency. From baby steps in shoppable services to the latest White House executive orders and the controversial rollout of a government-run drug pricing website, Rachel and Perry explore what’s driving this new wave of disruption in 2025. They unpack how these shifts could impact patients, payers, and PBMs, and what it means fo...
